BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1837478)

  • 1. Oral complications of cancer therapies: diagnosis, prevention, and treatment. The National Institutes of Health Consensus Development Conference Statement.
    Oncology (Williston Park); 1991 Jul; 5(7):64, 69-76, 79 passim. PubMed ID: 1837478
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus statement: oral complications of cancer therapies. National Institutes of Health Consensus Development Panel.
    NCI Monogr; 1990; (9):3-8. PubMed ID: 2188157
    [No Abstract]   [Full Text] [Related]  

  • 3. National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17-19, 1989.
    NCI Monogr; 1990; (9):1-184. PubMed ID: 2188147
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral complications of cancer therapies: diagnosis, prevention, and treatment.
    Natl Inst Health Consens Dev Conf Consens Statement; 1989 Apr 17-19; 7(7):1-11. PubMed ID: 2535680
    [No Abstract]   [Full Text] [Related]  

  • 5. National Institutes of Health consensus development conference statement: oral complications of cancer therapies: diagnosis, prevention, and treatment.
    J Am Dent Assoc; 1989 Jul; 119(1):179-83. PubMed ID: 2668375
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of oral complications in cancer patients.
    Peterson DE
    Prev Med; 1994 Sep; 23(5):763-5. PubMed ID: 7845955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral complications of cancer therapies: diagnosis, prevention, and treatment. National Institutes of Health.
    Conn Med; 1989 Oct; 53(10):595-601. PubMed ID: 2582763
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of acute and chronic oral complications of nonsurgical cancer therapies.
    Peterson DE; D'Ambrosio JA
    Dent Clin North Am; 1992 Oct; 36(4):945-66. PubMed ID: 1397442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral complications of cancer therapies. Oral complications in the pediatric population.
    Leggott PJ
    NCI Monogr; 1990; (9):129-32. PubMed ID: 2188150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH releases statement on oral complications of cancer therapies.
    Am Fam Physician; 1989 Nov; 40(5):301-4. PubMed ID: 2683691
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention and treatment of oral complications in the cancer patient.
    Poland J
    Oncology (Williston Park); 1991 Jul; 5(7):45-50; discussion 52, 57, 61-2. PubMed ID: 1837477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral complications of cancer therapies. Pretreatment oral assessment.
    Sonis ST; Woods PD; White BA
    NCI Monogr; 1990; (9):29-32. PubMed ID: 2342592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of oral complications associated with cancer therapy in pediatric patients.
    Simon AR; Roberts MW
    ASDC J Dent Child; 1991; 58(5):384-9. PubMed ID: 1939804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral complications of childhood cancer and its treatment: current best practice.
    Belfield PM; Dwyer AA
    Eur J Cancer; 2004 May; 40(7):1035-41; discussion 1042-4. PubMed ID: 15093579
    [No Abstract]   [Full Text] [Related]  

  • 15. Best practice in oral care for children and young people being treated for cancer: can we achieve consensus?
    Gibson F
    Eur J Cancer; 2004 May; 40(8):1109-10. PubMed ID: 15110873
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral complications of cancer therapies. Oral defenses and compromises: an overview.
    Silverman S
    NCI Monogr; 1990; (9):17-9. PubMed ID: 2188154
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral health in cancer therapy: evaluating and preventing oral complications.
    Rankin KV
    Dent Today; 2000 Sep; 19(9):60-5. PubMed ID: 12524728
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral management of the cancer patient. Part II: chemotherapy.
    Lunn R
    Probe; 1998; 32(2):58-65, 68. PubMed ID: 9791283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Institutes of Health consensus development conference statement CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J Ark Med Soc; 1981 Jun; 78(1):65-8. PubMed ID: 6454681
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral complications in children during cancer therapy.
    Niehaus CS; Meiller TF; Peterson DE; Overholser CD
    Cancer Nurs; 1987 Feb; 10(1):15-20. PubMed ID: 3644694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.